You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Sub-lineage of: BA.5.2 (ORF1b:T1050N) Earliest sequence: 2022-9-17, USA, Minnesota — EPI_ISL_15227102 Most recent sequence: 2022-11-22, New Zealand — EPI_ISL_15956989 Countries circulating: New Zealand (68), Australia (17), USA (2), South Korea (1), Thailand (1) Number of Sequences: 89 GISAID Query: Spike_K444Q, NS7a_A55V CovSpectrum Query: Nextcladepangolineage:BA.5.2* & ORF7a:A55V & S:K444Q Substitutions on top of BA.5.2 (ORF1b:T1050N): Spike: K444Q ORF7a: A55V Nucleotide: A8197G, T19896C, C21595T, A22892C, C25710T, C27557T
Evidence
Of the 89 sequences in this lineage, 68 were uploaded today, all from New Zealand. S:444 is probably the most prominent antibody escape mutation in the current global context. I’ve previously described (in issues #1110 and #1272) how S:K444Q stands out on the Bloom Lab RBD Heat Map as having the most favorable combination of ACE2 affinity and RBD expression of any of the 19 possible AA substitutions on a BA.2 background.
S:K444Q also appears to be the second-best mutation for evading neutralizing antibodies from breakthrough-infection convalescent sera.
This hasn’t, however, translated into real-world success in terms of the prevalence of this mutation. S:R444Q has occurred in a number of BA.5 lineages, but all have either died out or have shrunk to insignificant levels. This lineage appears to be an exception, though its growth seems primarily confined to New Zealand and Australia.
ryhisner
changed the title
Sublineage of BA.5.2 (ORF1b:T1050N) with S:K444Q & ORF7a:A55V (89 seq)
Sublineage of BA.5.2 (ORF1b:T1050N) with S:K444Q & ORF7a:A55V (92 seq)
Dec 3, 2022
Description
Sub-lineage of: BA.5.2 (ORF1b:T1050N)
Earliest sequence: 2022-9-17, USA, Minnesota — EPI_ISL_15227102
Most recent sequence: 2022-11-22, New Zealand — EPI_ISL_15956989
Countries circulating: New Zealand (68), Australia (17), USA (2), South Korea (1), Thailand (1)
Number of Sequences: 89
GISAID Query: Spike_K444Q, NS7a_A55V
CovSpectrum Query: Nextcladepangolineage:BA.5.2* & ORF7a:A55V & S:K444Q
Substitutions on top of BA.5.2 (ORF1b:T1050N):
Spike: K444Q
ORF7a: A55V
Nucleotide: A8197G, T19896C, C21595T, A22892C, C25710T, C27557T
USHER Tree
https://nextstrain.org/fetch/raw.githubusercontent.com/ryhisner/jsons/main/BA.5.2%20(T1050N)%20%2B%20K444Q%20%2B%20ORF7aA55V%20-%20subtreeAuspice1_genome_a48d_770360.json
Evidence
Of the 89 sequences in this lineage, 68 were uploaded today, all from New Zealand. S:444 is probably the most prominent antibody escape mutation in the current global context. I’ve previously described (in issues #1110 and #1272) how S:K444Q stands out on the Bloom Lab RBD Heat Map as having the most favorable combination of ACE2 affinity and RBD expression of any of the 19 possible AA substitutions on a BA.2 background.
S:K444Q also appears to be the second-best mutation for evading neutralizing antibodies from breakthrough-infection convalescent sera.
This hasn’t, however, translated into real-world success in terms of the prevalence of this mutation. S:R444Q has occurred in a number of BA.5 lineages, but all have either died out or have shrunk to insignificant levels. This lineage appears to be an exception, though its growth seems primarily confined to New Zealand and Australia.
Genomes
Genomes
EPI_ISL_15227102, EPI_ISL_15399291, EPI_ISL_15416413, EPI_ISL_15732157, EPI_ISL_15736397, EPI_ISL_15784105, EPI_ISL_15797328, EPI_ISL_15797567, EPI_ISL_15797771, EPI_ISL_15797799, EPI_ISL_15797897, EPI_ISL_15797930, EPI_ISL_15820571, EPI_ISL_15832186, EPI_ISL_15832312, EPI_ISL_15832602, EPI_ISL_15832620, EPI_ISL_15848882, EPI_ISL_15870943, EPI_ISL_15917287, EPI_ISL_15941947, EPI_ISL_15955562, EPI_ISL_15955659, EPI_ISL_15955875, EPI_ISL_15955900, EPI_ISL_15956016, EPI_ISL_15956060, EPI_ISL_15956289, EPI_ISL_15956335, EPI_ISL_15956349, EPI_ISL_15956371, EPI_ISL_15956403, EPI_ISL_15956438, EPI_ISL_15956444, EPI_ISL_15956445, EPI_ISL_15956483, EPI_ISL_15956484, EPI_ISL_15956552, EPI_ISL_15956567, EPI_ISL_15956646, EPI_ISL_15956665, EPI_ISL_15956699, EPI_ISL_15956731, EPI_ISL_15956759, EPI_ISL_15956792, EPI_ISL_15956872, EPI_ISL_15956915, EPI_ISL_15956968, EPI_ISL_15956971, EPI_ISL_15956978, EPI_ISL_15956986, EPI_ISL_15956989, EPI_ISL_15957065, EPI_ISL_15957069, EPI_ISL_15957088, EPI_ISL_15957090, EPI_ISL_15957097, EPI_ISL_15957208, EPI_ISL_15957449, EPI_ISL_15957456, EPI_ISL_15957490, EPI_ISL_15957512, EPI_ISL_15957710, EPI_ISL_15957783, EPI_ISL_15957806, EPI_ISL_15957903, EPI_ISL_15958112, EPI_ISL_15958122, EPI_ISL_15958131, EPI_ISL_15958151, EPI_ISL_15958176, EPI_ISL_15958217, EPI_ISL_15958246, EPI_ISL_15958254, EPI_ISL_15958264, EPI_ISL_15958290, EPI_ISL_15958298, EPI_ISL_15958329, EPI_ISL_15958334, EPI_ISL_15958335, EPI_ISL_15958370, EPI_ISL_15958382, EPI_ISL_15958450, EPI_ISL_15958541, EPI_ISL_15958625, EPI_ISL_15958689, EPI_ISL_15958786, EPI_ISL_15958824The text was updated successfully, but these errors were encountered: